MerckInc (MRK) has a profit margin of 4.77%, below the Healthcare sector average of 13.76%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for MRK is 4.77% as of June 2026. That compares with 25.79% in the prior-year period — down 81.5% year over year. That is below the Healthcare sector average of 13.76%. Investors often review this figure alongside MerckInc's historical trend and sector peers before judging valuation or financial health.
Over the past year, MRK's profit margin moved from 25.79% to 4.77% — a 81.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MerckInc's valuation or profitability profile.
Against Healthcare companies, MRK currently prints 4.77% for profit margin, while the sector average sits near 13.76%. That is roughly 65.4% below the sector mean. Large gaps often invite a closer look at MerckInc's growth, margins, and balance sheet.
Profit Margin shows how effectively MerckInc converts resources into returns. At 4.77%, MRK may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 25.79% in the prior-year period — down 81.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MRK's profit margin (4.77%), review year-over-year change from 25.79%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.